his hasn’t been a great year for companies promising to revolutionize blood draws. But startup Velano Vascular is no Theranos. The company, based in San Francisco, has received positive notice for its FDA-approved device, dubbed PIVO, which lets hospital clinicians draw blood through an existing IV line. We chatted with CEO Eric Stone.
How does your technology work?
Inpatient blood draws are critical medical procedures, but they’re performed so frequently that they turn patients into pincushions.